Engflag

Ceelin

Quick links to important sections

Ceelin

Ceelin_EN

Method of action: Antioxidant, Metabolic, Nutritive Agent, Regulating Redox Processes, Replenishing Vitamin C Deficiency, Vitamins

Treatment option: Beriberi, Anemia, Pregnancy, Addison Disease, Milk Ejection, Radiation Sickness, Nephropathy, Scurvy

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ceelin

Property Description
Active Ingredient Ascorbic Acid (as Sodium Ascorbate), with or without Zinc
Form Oral Drops, Syrup, Chewable Tablet
Pharmacological Class Vitamin and Nutritional Supplement
Common Use Providing the essential Vitamin C required for immune support
Origin Synthetic (chemically manufactured)

What Type of Essential Nutrient is Ceelin?

Ceelin is classified as an Over-The-Counter (OTC) nutritional supplement belonging to the pharmacological class of vitamins and minerals. Its primary active ingredient is Ascorbic Acid, widely recognized as Vitamin C, which is an essential nutrient that the human body cannot produce internally. This reliance on external sources underscores its vital role in foundational dietary support.

The preparation typically utilizes Sodium Ascorbate, a synthetic mineral salt derivative of Vitamin C. This unique formulation is clinically recognized for being a less acidic, buffered alternative compared to standard Ascorbic Acid, which significantly enhances tolerability, especially for the sensitive digestive systems of the target pediatric audience. Ceelin's positioning is rooted in nutritional maintenance rather than serving as an acute therapeutic drug.

Ceelin's Core Composition and Physical Forms

The composition centers on the Sodium Ascorbate ingredient. However, specific product variants are designated as combination products that integrate the trace mineral Zinc alongside the Vitamin C component, thereby delivering two distinct essential nutrients. Vitamin C acts as an antioxidant and is involved in numerous body functions.

For appropriate oral route of administration across different age groups, the product line is specifically manufactured to include various appealing pharmaceutical preparations. These forms, such as Oral Drops and Syrup (liquid form) for infants and young children, as well as Chewable Tablets for older children, ensure practical and effective intake of the required nutrients across the target segment.

What General Benefits Does Ceelin Provide?

The general benefit of Ceelin is to support key physiological actions by reliably providing the necessary Vitamin C intake. Its core function is rooted in the fact that Ascorbic Acid is a powerful water-soluble antioxidant. Furthermore, the nutrient is a critical cofactor necessary for collagen formation, a process essential for maintaining strong connective tissues and playing a fundamental part in promoting tissue repair. By supporting these foundational processes, the supplement contributes to the general defense and proper function of the body, which includes supporting immune function.

What side effects are possible with Ceelin?

Possible Side Effects and Safety Information

The safety profile of Ceelin (Ascorbic Acid pm Zinc) is organized by the types of adverse reactions documented in regulatory sources, which are often dose-dependent.

Common and Dose-Related Adverse Reactions

Ascorbic acid and zinc are generally well tolerated. However, at higher doses (typically 1 gram or more daily for Ascorbic Acid, or ge 30 mg elemental zinc), gastrointestinal side effects are the most commonly reported category:

  • Gastrointestinal Disorders: Nausea, vomiting, diarrhea, abdominal cramps, and heartburn.
  • General Disorders: Fatigue, flushing, insomnia, or sleepiness may be reported with high doses of Vitamin C.

Serious Adverse Reactions

Rare but clinically significant adverse reactions that have been documented, especially with very high or prolonged intake, include those affecting the renal and hematopoietic systems:

  • Renal and Urinary Disorders: Formation of renal oxalate calculi (kidney stones), particularly in individuals with a history of kidney stones or pre-existing renal insufficiency. Acute renal tubular necrosis has been reported in cases of massive overdose.
  • Blood and Lymphatic System Disorders: Hemolysis (destruction of red blood cells) in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. Prolonged, high-dose zinc intake may lead to copper deficiency, potentially causing sideroblastic anemia and neutropenia.

Safety Restrictions and Limitations

Official regulatory information includes specific limitations on use:

  • Contraindications: The product is restricted or contraindicated in patients with certain conditions, including known Hypersensitivity to the ingredients, severe renal impairment/insufficiency, hemochromatosis (iron overload), and conditions associated with elevated oxalate (like hyperoxaluria or a history of nephrolithiasis).
  • G6PD Deficiency: Caution and strict adherence to recommended daily allowances are required for individuals with G6PD deficiency due to the risk of hemolysis.
  • Lab Tests: Ascorbic Acid can interfere with certain laboratory tests, such as those for urinary glucose and occult blood.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for overdose of Ascorbic Acid (Vitamin C) and Zinc is defined by potential clinical manifestations and mandated emergency actions. Overdosage, especially chronic intake exceeding 2 g per day, is documented to cause prominent gastrointestinal effects, including Nausea, Vomiting, Diarrhea, and Abdominal cramps. Other reported systemic disturbances include Fatigue, Insomnia, and Flushing.

Serious Outcomes and High-Risk Populations

Severe outcomes documented in regulatory sources primarily involve the renal and hematologic systems. Overdosage carries a risk of Oxalate Nephropathy (kidney damage) and the formation of kidney stones (Nephrolithiasis). In specific high-risk patients, particularly those with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, high doses have been associated with Haemolytic Anaemia (red blood cell breakdown).

Risk for renal complications is noted in patients with existing renal impairment or a history of oxalate kidney stones, and in certain pediatric and geriatric populations.

Emergency Actions

The regulatory guidance is explicit that individuals must seek immediate medical attention or contact a poison control center at once if an overdosage is suspected or if any severe adverse symptoms occur. Management is officially described as symptomatic and supportive treatment, as no specific antidote is currently documented in the regulatory prescribing information. Monitoring of renal function and blood count is required for patients with documented risk factors following suspected overdose.

Therapeutic Uses of Ceelin

Key Therapeutic Domains of Ceelin (Ascorbic Acid)

Ceelin, which contains Ascorbic Acid (Vitamin C), is commonly used in situations involving certain distressing symptoms, particularly those associated with vitamin C deficiency. The most specific therapeutic context involves assistance with conditions marked by symptoms related to vitamin C deficiency, such as symptoms related to physical discomfort and systemic imbalance.

Beyond addressing severe deficiency, Ascorbic Acid is commonly used to help with general well-being during symptomatic phases. This nutrient is considered relevant for easing symptoms that interfere with daily comfort. It is applied in contexts that include the management of scurvy and situations where the body requires additional management of discomfort due to increased physiological stress. The supplement provides support that helps ease the overall symptom burden, which generally contributes to improved comfort during periods of heightened symptoms by supporting stability when symptoms are more noticeable.

This makes it relevant when supportive symptom management is appropriate in clinical settings that involve acute or unstable symptom patterns. In these clinical contexts, it is observed that: “This supplement supports the patient during difficult episodes by easing distress and is commonly used to help with general well-being.”

Quick Fact: Relevant for Symptom Clusters The use of Ascorbic Acid is relevant for managing symptom clusters that may become intense or disruptive, helping patients cope more steadily with symptom fluctuations.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Ceelin? - Official Regulatory Information

The eligibility for Ceelin, an Ascorbic Acid-based supplement, is defined by regulatory documents focusing on patient age, known metabolic disorders, and renal function.

Eligibility scope Statement based on Regulatory Documents
Populations for whom use is allowed Pediatric patients age 5 months and older and adults are permitted to use Ascorbic Acid under standard labeled conditions [3.1].
Populations for whom use is contraindicated Individuals with known hypersensitivity to Ascorbic Acid or any excipient are contraindicated [1.2]. Use is contraindicated in patients with iron storage diseases (e.g., Haemochromatosis, Thalassaemia) [1.1].
Age-related eligibility rules Pediatric patients less than 2 years old and geriatric patients require caution due to an increased risk of oxalate nephropathy [2.1]. Infants under 5 months are outside the established use period for some therapeutic forms [3.1].
Condition-specific eligibility rules Patients with renal impairment, a history of kidney stones, or those on dialysis must adhere to strictly limited daily doses (e.g., 60 to 100 mg per day) [2.2]. Use is restricted in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency due to the risk of hemolysis [1.3].
Pregnancy and lactation eligibility status Use is permitted, but intake must not exceed the U.S. Recommended Dietary Allowance (RDA) for Ascorbic Acid [2.3].

Eligibility Classifications

Classification Detail Regulatory Statement Summary
Eligibility severity classification Contraindicated (absolute prohibition), Restricted (conditional use with dose limitations), Caution Required (monitoring or special consideration) [3.2].
Eligibility-context constraints Eligibility is constrained by pre-existing metabolic disorders (e.g., iron storage diseases) and the functionality of the renal system [1.1, 2.1].

Resulting Eligibility Structure

Official eligibility statements:

  • The supplement is contraindicated in patients with hypersensitivity and iron storage diseases [1.1, 1.2].
  • Patients with renal impairment or on dialysis must strictly limit their daily intake to prevent oxalate accumulation [2.2].
  • Use in children less than 2 years and in older adults requires caution due to a higher risk of oxalate nephropathy [2.1].

Connection to the overall eligibility profile

Official government documents define who can and cannot use the medicine by establishing absolute non-eligibility based on hypersensitivity and certain high-iron and kidney stone disorders. The profile further stipulates that use is conditional across specific age groups and in patients with compromised renal function or metabolic disorders (G6PD deficiency), mandating strict regulatory intake limits.

What should I know about interactions with other medicines?

The official regulatory profile for Ascorbic Acid (Vitamin C) and its Zinc-containing combinations outlines several interactions that impact co-administered medications through altered clearance, chelation, or therapeutic interference. The Ascorbic Acid component can alter the renal clearance of certain basic drugs, such as Amphetamines, by acidifying the urine, which results in a lower serum concentration of the co-administered drug. It may also increase the absorption of Aluminum from antacids, posing a specific risk for patients with kidney conditions. High-dose Ascorbic Acid is documented to interfere with the effects of Warfarin and may diminish the effectiveness of chemotherapy agents. In products containing Zinc, the potential for chelation creates mandatory timing restrictions. Co-administration with Tetracycline-class and Quinolone antibiotics causes a reduction in the antibiotic's absorption and efficacy, requiring a separation of at least two hours before or four to six hours after the antibiotic dose. Zinc-related chelation also affects drugs like Deferasirox and Penicillamine. Specific patient populations carry regulatory cautions: Ascorbic Acid administration presents a risk of severe hemolysis in individuals with G6PD deficiency and an increased risk of oxalate stone precipitation in patients with renal impairment.

Mechanism of Action

Molecular Mechanism: Redox Activity

Ceelin's active ingredient, ascorbic acid, is a water-soluble electron donor. It functions by transferring electrons to neutralize highly reactive oxygen species (ROS) and free radicals, acting as a substrate that is consumed in the process.

Cofactor Function in Enzymatic Pathways

Ascorbic acid is a critical cofactor for several hydroxylase and monooxygenase enzymes. It is required for the activity of prolyl and lysyl hydroxylases, maintaining the iron atom of these enzymes in its required reduced state ( Fe^2+). This maintenance is essential for the stabilization and folding steps in collagen synthesis.

Regeneration and Cellular Processes

The molecule also participates in the regeneration of other cellular antioxidants. Specifically, it reduces oxidized alpha-tocopherol ( Vitamin E), restoring its active antioxidant form. Furthermore, ascorbic acid is required for optimal lymphocyte function, supporting the proliferation and maturity of these cellular components.

Dosage and Administration Information

Instruction Map: How to use Ceelin — General Administration Guidelines

This section outlines the administration instructions for Ascorbic Acid (the active ingredient in Ceelin) for its use as an oral nutritional supplement.

Administration Scope

Instruction Detail
Route of administration: Oral route only, utilizing liquid (Drops/Syrup) or solid (Chewable Tablet) forms.
Dosing schedule: Nutritional Maintenance: Standard adult dosing ranges from 50 mg to 200 mg daily. The established safe upper limit for daily adult intake is 2,000 mg.
Timing in relation to meals (if applicable): May be taken with or without food.
Preparation requirements (if applicable): Liquid forms must be precisely measured using the dedicated calibrated dropper or measuring spoon provided.
Age-group administration rules: Dosing and form selection are stratified by age; Drops/Syrup are specified for infants and young children, while Chewable Tablets are for older children/adults.
Missed-dose rules: If a dose is missed, do not take a double dose; continue with the next scheduled dose at the regular time.

Instruction Classifications (High-Level)

Classification Detail
Administration method type: Oral (Ingestion)
Frequency pattern: Daily (Once Daily or in divided doses) for continuous nutritional support.

Resulting Procedural Structure

Official step sequence:

  • Select the age-appropriate dosage form and measure the specific dose using a calibrated device for liquid forms.
  • Administer the measured dose orally.

Connection to the overall use protocol

The procedural steps define a continuous oral protocol for supplementation, emphasizing dosing accuracy through the use of calibrated tools and age-appropriate formulations. This approach is standardized for the non-acute, long-term administration of this essential nutrient.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ceelin

The evidence base for Ceelin, which contains Ascorbic Acid (Vitamin C) and sometimes Zinc, is derived from research documented in peer-reviewed scientific literature and regulatory summaries. Research has studied the effects of these essential nutrients, with focus on various physiological outcomes, primarily through Randomized Controlled Trials (RCTs) and Systematic Reviews. Research examines the relationship between nutrient status and group patterns in specific health situations, not the outcomes for any individual person.

Evidence for Use in Managing Symptoms of the Common Cold

Research documented in authoritative sources has explored the relationship between Ascorbic Acid supplementation and the common cold. Studies were designed to measure two primary outcomes: the mean duration of the cold episode and the severity of the symptoms experienced. The findings related to cold duration have been inconsistent across studies in the general, healthy population. While some studies reported measurements of cold duration that differed from placebo, other findings were less consistent. Research has described patterns related to symptom duration in sub-groups, such as individuals undergoing brief, severe physical stress.

Research has explored the initial incidence of the common cold in typical, well-nourished individuals, but conclusive evidence is lacking. Furthermore, the overall research landscape related to starting supplementation once cold symptoms are present (therapeutic use) is not consistently supported by research, with many trials providing limited insight into this approach.

Evidence for Essential Nutrient Support in Infectious Illnesses

For combination products containing both Ascorbic Acid and Zinc, research has been conducted using RCTs to examine the relationship between nutrient levels and outcomes during infectious illnesses. These studies have primarily focused on children in areas with a high prevalence of nutrient deficiency, tracking outcomes like the incidence and duration of specific infectious diseases. The relevance of these findings to healthy populations who are already well-nourished has not been clearly established by research, as the observed patterns in nutrient-deficient groups may not translate to similar outcomes.

Key Studies & References

  1. Vitamin C: Uses, Side Effects, Interactions, Dosage, and Warning (MedlinePlus Drug Information)

How should Ceelin be stored and disposed of?

The official labeling for Ceelin (Ascorbic Acid) defines the mandatory conditions for storage, handling, and disposal.

Official Storage Requirements

Storage Factor Regulatory Requirement
Temperature Must be stored in a cool, dry place. Store at temperatures not exceeding 25 C or 30 C, depending on the formulation.
Protection Must be protected from light, direct heat, and sunlight. The container must be kept tightly closed to maintain product integrity.
Child Safety The medicine must be kept out of the sight and reach of children to prevent accidental ingestion.

Official Disposal Instructions

Disposal of unused, expired, or unwanted Ceelin must adhere to applicable local regulations for pharmaceutical waste. General guidance from regulatory bodies advises against discarding the medicine by flushing it down the toilet or drain to prevent environmental contamination. The product should be disposed of via an approved waste disposal program or managed according to local community collection rules.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagIndonesia

flagMyanmar

flagPhilippines

flagVietnam

Equivalent of Ceelin found in:

A-Z Index: